199 related articles for article (PubMed ID: 30275152)
1. Targeting Canine
Zorzan E; Da Ros S; Giantin M; Shahidian LZ; Guerra G; Palumbo M; Sissi C; Dacasto M
J Pharmacol Exp Ther; 2018 Dec; 367(3):461-472. PubMed ID: 30275152
[TBL] [Abstract][Full Text] [Related]
2. Screening of candidate G-quadruplex ligands for the human c-KIT promotorial region and their effects in multiple in-vitro models.
Zorzan E; Da Ros S; Musetti C; Shahidian LZ; Coelho NF; Bonsembiante F; Létard S; Gelain ME; Palumbo M; Dubreuil P; Giantin M; Sissi C; Dacasto M
Oncotarget; 2016 Apr; 7(16):21658-75. PubMed ID: 26942875
[TBL] [Abstract][Full Text] [Related]
3. Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule.
Zorzan E; Elgendy R; Giantin M; Dacasto M; Sissi C
Sci Rep; 2018 Nov; 8(1):17107. PubMed ID: 30459395
[TBL] [Abstract][Full Text] [Related]
4. Targeting G-quadruplex DNA structures in the telomere and oncogene promoter regions by benzimidazole‒carbazole ligands.
Kaulage MH; Maji B; Pasadi S; Ali A; Bhattacharya S; Muniyappa K
Eur J Med Chem; 2018 Mar; 148():178-194. PubMed ID: 29459277
[TBL] [Abstract][Full Text] [Related]
5. Sequencing and G-quadruplex folding of the canine proto-oncogene KIT promoter region: might dog be used as a model for human disease?
Da Ros S; Zorzan E; Giantin M; Zorro Shahidian L; Palumbo M; Dacasto M; Sissi C
PLoS One; 2014; 9(8):e103876. PubMed ID: 25084283
[TBL] [Abstract][Full Text] [Related]
6. G-Quadruplex Modulation of SP1 Functional Binding Sites at the
Da Ros S; Nicoletto G; Rigo R; Ceschi S; Zorzan E; Dacasto M; Giantin M; Sissi C
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396937
[TBL] [Abstract][Full Text] [Related]
7. Benzothiazole hydrazones of furylbenzamides preferentially stabilize c-MYC and c-KIT1 promoter G-quadruplex DNAs.
Pany SP; Bommisetti P; Diveshkumar KV; Pradeepkumar PI
Org Biomol Chem; 2016 Jun; 14(24):5779-93. PubMed ID: 27021281
[TBL] [Abstract][Full Text] [Related]
8. Fe
Malina J; Kostrhunova H; Scott P; Brabec V
Chemistry; 2021 Aug; 27(45):11682-11692. PubMed ID: 34048082
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of 7-substituted-5,6-dihydrobenzo[c]acridine derivatives as new c-KIT promoter G-quadruplex binding ligands.
Guo QL; Su HF; Wang N; Liao SR; Lu YT; Ou TM; Tan JH; Li D; Huang ZS
Eur J Med Chem; 2017 Apr; 130():458-471. PubMed ID: 28284084
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit.
London CA; Galli SJ; Yuuki T; Hu ZQ; Helfand SC; Geissler EN
Exp Hematol; 1999 Apr; 27(4):689-97. PubMed ID: 10210327
[TBL] [Abstract][Full Text] [Related]
11. Solution structures of all parallel-stranded monomeric and dimeric G-quadruplex scaffolds of the human c-kit2 promoter.
Kuryavyi V; Phan AT; Patel DJ
Nucleic Acids Res; 2010 Oct; 38(19):6757-73. PubMed ID: 20566478
[TBL] [Abstract][Full Text] [Related]
12. Perylene and coronene derivatives binding to G-rich promoter oncogene sequences efficiently reduce their expression in cancer cells.
Micheli E; Altieri A; Cianni L; Cingolani C; Iachettini S; Bianco A; Leonetti C; Cacchione S; Biroccio A; Franceschin M; Rizzo A
Biochimie; 2016 Jun; 125():223-31. PubMed ID: 27086081
[TBL] [Abstract][Full Text] [Related]
13. G-quadruplex-binding benzo[a]phenoxazines down-regulate c-KIT expression in human gastric carcinoma cells.
McLuckie KI; Waller ZA; Sanders DA; Alves D; Rodriguez R; Dash J; McKenzie GJ; Venkitaraman AR; Balasubramanian S
J Am Chem Soc; 2011 Mar; 133(8):2658-63. PubMed ID: 21294544
[TBL] [Abstract][Full Text] [Related]
14. Specific stabilization of promoter G-Quadruplex DNA by 2,6-disubstituted amidoanthracene-9,10-dione based dimeric distamycin analogues and their selective cancer cell cytotoxicity.
Roy S; Ali A; Kamra M; Muniyappa K; Bhattacharya S
Eur J Med Chem; 2020 Jun; 195():112202. PubMed ID: 32302880
[TBL] [Abstract][Full Text] [Related]
15. Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives.
Brito H; Martins AC; Lavrado J; Mendes E; Francisco AP; Santos SA; Ohnmacht SA; Kim NS; Rodrigues CM; Moreira R; Neidle S; Borralho PM; Paulo A
PLoS One; 2015; 10(5):e0126891. PubMed ID: 26024321
[TBL] [Abstract][Full Text] [Related]
16. Destabilisation of the c-kit1 G-quadruplex structure by N
Laddachote S; Nagata M; Yoshida W
Biochem Biophys Res Commun; 2020 Apr; 524(2):472-476. PubMed ID: 32008744
[TBL] [Abstract][Full Text] [Related]
17. Conformational profiling of a G-rich sequence within the c-KIT promoter.
Rigo R; Dean WL; Gray RD; Chaires JB; Sissi C
Nucleic Acids Res; 2017 Dec; 45(22):13056-13067. PubMed ID: 29069417
[TBL] [Abstract][Full Text] [Related]
18. Interplay of Three G-Quadruplex Units in the KIT Promoter.
Ducani C; Bernardinelli G; Högberg B; Keppler BK; Terenzi A
J Am Chem Soc; 2019 Jul; 141(26):10205-10213. PubMed ID: 31244182
[TBL] [Abstract][Full Text] [Related]
19. Double-stranded flanking ends affect the folding kinetics and conformational equilibrium of G-quadruplexes forming sequences within the promoter of KIT oncogene.
Vesco G; Lamperti M; Salerno D; Marrano CA; Cassina V; Rigo R; Buglione E; Bondani M; Nicoletto G; Mantegazza F; Sissi C; Nardo L
Nucleic Acids Res; 2021 Sep; 49(17):9724-9737. PubMed ID: 34478543
[TBL] [Abstract][Full Text] [Related]
20. Expression of c-kit proto-oncogene in canine mastocytoma: a kinetic study using real-time polymerase chain reaction.
Turin L; Acocella F; Stefanello D; Oseliero A; Fondrini D; Brizzola S; Riva F
J Vet Diagn Invest; 2006 Jul; 18(4):343-9. PubMed ID: 16921872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
